All News #Library
Others
Alpha-9 Oncology Names Paul Blanchfield at CEO
10 Nov 2025 //
PR NEWSWIRE
Alpha-9 Oncology Secures $175 Million For Clinical Pipeline
23 Oct 2024 //
PR NEWSWIRE
Alpha-9 Oncology Appoints Jean-Jacques and Dr. Steven to its BoD
15 Oct 2024 //
PR NEWSWIRE
Alpha-9 Doses First Patient In Phase 1 A9-3202 Melanoma Study
02 May 2024 //
PR NEWSWIRE

Market Place
Sourcing Support